Oncogenic kinases of myeloproliferative disorders induce both protein synthesis and G1 activators
- 10 August 2006
- journal article
- Published by Springer Nature in Leukemia
- Vol. 20 (10) , 1885-1888
- https://doi.org/10.1038/sj.leu.2404361
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Activated Jak2 with the V617F Point Mutation Promotes G1/S Phase TransitionJournal of Biological Chemistry, 2006
- Chronic myeloproliferative disorders: a tyrosine kinase taleLeukemia, 2005
- The STAT3 Transcription Factor Is a Target for the Myc and Riboblastoma Proteins on the Cdc25A PromoterJournal of Biological Chemistry, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc ExpressionJournal of Biological Chemistry, 2004
- Growth Suppression by Acute PromyelocyticLeukemia-Associated Protein PLZF Is Mediated by Repression of c-myc ExpressionMolecular and Cellular Biology, 2003
- An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targetsGenome Biology, 2003
- NoBP, a Nuclear Fibroblast Growth Factor 3 Binding Protein, Is Cell Cycle Regulated and Promotes Cell GrowthMolecular and Cellular Biology, 2001
- BCR-ABL and Interleukin 3 Promote Haematopoietic Cell Proliferation and Survival through Modulation of Cyclin D2 and p27Kip1 ExpressionPublished by Elsevier ,2001